Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1995-04-07
2000-03-21
Azpuru, Carlos A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
424451, 424464, A61F 202, A61K 920, A61K 948
Patent
active
060403004
ABSTRACT:
A method for preventing the initiation of colon cancer is disclosed. Vitamin D.sub.3 analogues prevented the development of adenomas and adenocarcinomas when administered to rats prior to, and subsequent to, chemically induced tumorigenesis.
REFERENCES:
patent: 5451574 (1995-09-01), Baggliolini et al.
Shabahang et al., "A Comparison of the Antiproliferative effect of 1,25-Dihydroxyvitamin D.sub.3 and Three Analogs in Colon Carcinoma Cell Lines," Endocrinology, Proceedings of the American Association for Cancer Research, Abstract No. 1453, 34:244, Mar. 1993.
Steele et al., "Preclinical Efficacy Evaluation of Potential Chemopreventive Agents in Animal Carcinogenesis Models: Methods and Results from the NCI Chemoprevention Drug Development Program," Journal of Cellular Biochemistry, Supplement 20:32-54, 1994.
Wali et al., "1.alpha.,25-Dihydroxy-16-Ene-26,27-Hexa-Fluorocholecalciferol (Ro24-5531), a Non-Calcemic Analog of 1.alpha.,25-Dihydroxyvitamin D.sub.3, Inhibits Azoxymethane-Induced Colonic Tumorigenesis," Gastroenterology, 108(4):A550, Apr. 1995.
International Search Report dated Aug. 13, 1996.
Anzano et al., "1.alpha.,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a New Deltanoid (Vitamin D Analogue) for Prevention of Breast Cancer in the Rat," Canc. Res., 54:1653-1656, Apr. 1, 1994.
Belleli et al., "A protective role of 1,25-dihydroxyvitamin D.sub.3 in chemically induced rat colon carcinogenesis," Carcinogenesis, 13(12):2293-2298, 1992.
Earnest et al., "Chemoprevention of Azoxymethane-induced Colonic Carcinogenesis by Supplemental Dietary Ursodeoxycholic Acid," Canc. Res., 54:5071-5074, Oct. 1, 1994.
Ferrera et al., "Highly Potent Transcriptional Activation by 16-ene Derivatives of 1,25-dihydroxyvitamin D.sub.3," J. Biol. Chem., 269(4):2971-2981, 1994.
Fiala et al., "Inhibition of the Metabolism of the Colon Carcinogen, Azoxymethane, by Pyrazole," Canc. Res., 38:4515-4521, Dec. 1978.
Garland et al., "Dietary Vitamin D and Calcium and Risk of Colorectal Cancer: A 19-Year Prospective Study in Men," Lancet, pp. 307-309, Feb. 9, 1985.
Garland and Garland, "Do Sunlight and Vitamin D Reduce the Likelihood of Colon Cancer," Int. J. Epidem., 9(3):227-231, 1980.
Garland et al., "Can colon cancer incidence and death rates be reduced with calcium and vitamin D," Am. J. Clin. Nutr., 54:193S-201S, 1991.
Halline et al., "Effects of 1,25-Dihydroxyvitamin D.sub.3 on Proliferation and Differentiation of Caco-2 Cells," Endocrinology, 134(4):1710-1717, 1994.
Ikekawa and Ishizuka, "Molecular Structure and Biological Activity of Vitamin D Metabolites and their Analogs" Molecular Structure and Biological Activity of Steroids, Ch. 8, pp. 293-316, Bohl and Duax, eds., CRC Press, Boca Raton, Fl, 1992.
Kawaura et al., "Supplemental administration of 1.alpha.-hydroxyvitamin D.sub.3 inhibits promoter by intrarectal instillation of lithocholic acid in N-methyl-Nenitrosourea-induced colonic tumorigenesis in rats," Carcinogenesis, 10(4):647-649, 1989.
Kawaura et al., "1.alpha.-Hydroxyvitamin D.sub.3 suppresses colonic tumorigenesis induced by repetitive intrarectal injection of N-methyl-N-nitrosourea in rats," Canc. Lett, 55:149-152, 1990.
Llor et al., "K-ras Mutations in 1,2-Dimethylhydrazine-induced Colonic Tumors: Effects of Supplemental Dietary Calcium and Vitamin D Deficiency," Canc. Res., 51:4305-4309, Aug. 15, 1991.
Niendorf et al., "Effect of 1,25-Dihydroxyvitamin D.sub.3 on Human Cancer Cells In Vitro," J. steroid Biochem., 27(4-6):825-828, 1987.
Pence and Buddingh, "Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D.sub.3, " 9(1):187-190, 1988.
Sitrin et al., "Dietary Calcium and Vitamin D Modulate 1,2-Dimethylhdrazine-induced Colonic Carginogenesis in the Rat," Cancer Research, 51:5608-5613, Oct. 15, 1991.
Wali et al., 1.alpha.,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, a Noncalcemic Analogue of 1.alpha.,25-Dihydroxyvitamin D.sub.3, Inhibits Azoxymethane-induced Colonic Tumorigenesis.sup.1, Cancer Research, 55:3050-3054, Jul. 15, 1995.
Zhou et al., "Development of a Novel 1,25-(OH).sub.2 -Vitamin D.sub.3 Analog with Potent Ability to Induce HL-60 Cell Differentiation Without Modulating Calcium Metabolism," Blood, 78(1):75-82, Jul. 1, 1992.
Willett, W., "The search for the causes of breast and colon cancer," Nature, 338:389-394, Mar. 30, 1989.
Zhou et al., "1,25-Dihydroxy-16-ene-23-yne-vitamin D.sub.3 prolongs survival time of leukemic mice," Proc. Natl. Acad. Sci. USA, 87:3929-3932, May 1990.
Wilhelm et al., "6-Fluoro-Vitamin D.sub.3 : A New Antagonist of the Biological Actions of Vitamin D.sub.3 and its Metabolites Which Interacts with the Intestinal Receptor for 1.alpha., 25 (OH).sub.2 -Vitamin D .sub.3 ,"Arch Biochem. Biophys,233(1): 127-132, 1984.
Bissonnette Bruce Marc
Brasitus Thomas A.
Sitrin Michael D.
ARCH Development Corporation
Azpuru Carlos A.
LandOfFree
Method of preventing colon cancer with vitamin D.sub.3 analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preventing colon cancer with vitamin D.sub.3 analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preventing colon cancer with vitamin D.sub.3 analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-730486